Diabetes, chronic kidney disease and cancer risk

Nephrology Dialysis Transplantation

Volumn 27, Issue 8, 2012, Pages 3018-3020

  Hartmann, Anders ^a   Jenssen, Trond ^a,b   Holdaas, Hallvard ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

INDAPAMIDE; INSULIN; INTERLEUKIN 6; LEPTIN; METFORMIN; MONOCYTE CHEMOTACTIC PROTEIN; PLACEBO; PLASMINOGEN ACTIVATOR INHIBITOR 1; SOMATOMEDIN C; SULFONYLUREA; TUMOR NECROSIS FACTOR ALPHA;

AGE; ALBUMINURIA; ARTICLE; CANCER INCIDENCE; CANCER RISK; CELL METABOLISM; CHRONIC KIDNEY DISEASE; CYTOKINE RELEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DRUG MECHANISM; HUMAN; HYPERINSULINEMIA; KIDNEY FAILURE; MALIGNANT NEOPLASTIC DISEASE; MALIGNANT TRANSFORMATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; TUMOR PROMOTION;

DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; NEOPLASMS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 84864607999     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs175     Document Type: Article

References (28)

1. Wilson EB, Maher HC. Cancer and tuberculosis with some comments on cancer and other diseases. Am J Cancer 1932; 16: 227-250.
2. El-Serag HB, Hampel H, Javadi F. The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol 2006; 4: 369-380.
3. Huxley R, Ansary-Moghaddam A, Berrington de Gonzalez A et al. Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer 2005; 92: 2076-2083.
4. Friberg E, Orsini N, Mantzoros CS et al. Diabetes mellitus and risk of endometrial cancer: a meta- analysis. Diabetologia 2007; 50: 1365-1374.
5. Peairs KS, Barone BB, Snyder CF et al. Diabetes mellitus and breast cancer outcomes: a systematic review and meta-analysis. J Clin Oncol 2011; 29: 40-46.
6. Larsson SC, Orsini N, Wolk A. Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst 2005; 97: 1679-1687.
7. MacKenzie T, Lens MS, Ferrara A et al. Diabetes and risk of bladder cancer: evidence from a case-control study in New England. Cancer 2010; 117: 1552-1556.
8. Larsson SC, Wolk A. Diabetes mellitus and incidence of kidney cancer: a meta-analysis of cohort studies. Diabetologia 2011; 54: 1013-1018.
9. Kasper JS, Giovannucci E. A meta-analysis of diabetes mellitus and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2006; 15: 2056-2062.
10. Barone BB, Yeh HC, Snyder CF et al. Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus. A systematic review and meta-analysis. JAMA 2008; 300: 2754-2764.
11. Carroll KK. Obesity as a risk factor for certain types of cancer. Lipids 1998; 33: 1055-1059.
12. Calle EE, Rodriguez C, Walker-Thurmond K et al. Overweight, obesity and mortality from cancer in a prospectively studied cohort of US adults. New Engl J Med 2003; 348: 1625-1638.
13. Zendedehl K, Nyrèn O, Östenson CG et al. Cancer incidence in patients with type 1 diabetes mellitus: a population based cohort study in Sweden. J Natl Cancer Inst 2003; 95: 1797-1800.
14. Piatkiewicz P, Czech A. Glucose metabolism disorders and the risk of cancer. Arch Immunol Ther Exp 2011; 59: 215-230.
15. Smith U, Gale EAM. Cancer and diabetes: are we ready for prime time? Diabetologia 2010; 53: 1541-1544.
16. Johnson JA, Pollak M. Insulin, glucose and the increased risk of cancer in patients with type 2 diabetes. Diabetologia 2010; 53: 2086-2088.
17. Warburg O, Wind F, Negelein E. The metabolism of tumours in the body. J Gen Physiol 1927; 8: 519-530.
18. Currie CJ, Poole CD, Gale EA. The influence of glucose-lowering therapies on cancer risk in type 2 diabetes. Diabetologia 2009; 52: 1766-1777.
19. Libby G, Alessi DR, Donnelly LA et al. New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes. Diabetes Care 2009; 32: 1620-1625.
20. Gallagher EJ, LeRoith D. Diabetes, cancer, and metformin: connections of metabolism and cell proliferation. Ann N Y Acad Sci 2011; 1243: 54-68.
21. Zakikhani M, Dowling R, Fantus IG et al. Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells. Cancer Res 2006; 66: 10269-10273.
22. Wong G, Zoungas S, Lo S. The risk of cancer in people with diabetes and chronic kidney disease. Nephrol Dial Transplant. 2012 [Epub ahead of print] February.
23. Patel A, MacMahon S, Chalmers J et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358: 2560-2572 [Epub 2008 Jun 6].
24. Vajdic CM, McDonald SP, McCredie MR et al. Cancer incidence before and after kidney transplantation. JAMA 2006; 296: 2823-2831.
25. Go AS, Chertow GM, Fan D et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305.
26. Wong G, Hayen A, Chapman JR et al. Association of CKD and cancer risk in older people. J Am Soc Nephrol. 2009; 20: 1341-1350 [Epub 2009 Apr 30].
27. Klausen K, Borch Johnsen K, Feldt-Rasmussen B et al. Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation 2004; 110: 32-35.
28. Jørgensen L, Heuch I, Jenssen T, Jacobsen BK. Association of albuminuria and cancer incidence. J Am Soc Nephrol. 2008; 19: 992-998 [Epub 2008 Feb 6].